Tebain
| Nazivi | |
|---|---|
| IUPAC nazivs
6,7,8,14-tetradehydro-4,5a-epoxy-
3,6-dimethoxy-17-methylmorphinan | |
| Drugi nazivi
Paramorfin
| |
| Identifikacija | |
3D model (Jmol)
|
|
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.003.713 |
| KEGG[1] | |
| MeSH | Tebain |
| UNII | |
| |
| Svojstva | |
| C19H21NO3 | |
| Molarna masa | 311,37 g/mol |
| Farmakologija | |
| Farmakokinetika: | |
| O-demetilacija[4] | |
| Pravni status |
|
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Tebain (paramorfin) je opijatni alkaloid. Njegovi ime potiče od grč. Θῆβαι - Teba, drevni grad u gornjem Egiptu. Manjinski konstituent opijuma, tebain je hemijski sličan morfinu i kodeinu, ali ima stimulatorne umesto depresantskih efekata. On izaziva konvulzije slično strihninskom trovanju u većim dozama. Međutim veštački enantiomer (+)-tebain pokazuje analgetičko dejstvo, koje je posredovano putem opioidnih receptora.[6] Tebain nema terapeutsku primenu, ali kao glavni alkaloid ekstrahovan iz Papaver bracteatum, on se konvertovuje u niz jedinjenja: oksikodon, oksimorfon, nalbufin, nalokson, naltrekson, buprenorfin i etorfin.
Literatura
- ^ Joanne Wixon; Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast. 17 (1): 48—55. doi:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Mikus G, Somogyi AA, Bochner F, Eichelbaum M (1991). „Thebaine O-demethylation to oripavine: genetic differences between two rat strains”. Xenobiotica. 21 (11): 1501—9. PMID 1763524.
- ^ WHO Advisory Group. (1980). „The dependence potential of thebaine”. Bulletin on Narcotics. 32 (1): 45—54. PMID 6778542. Архивирано из оригинала 29. 05. 2005. г. Приступљено 08. 05. 2011.
- ^ Aceto MD, Harris LS, Abood ME, Rice KC (1999 Jan 22). „Stereoselective mu- and delta-opioid receptor-related antinociception and binding with (+)-thebaine”. European Journal of Pharmacology. 365 ((2-3)): 143—7. PMID 9988096. Проверите вредност парамет(а)ра за датум:
|date=(помоћ)
| Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.